Home Cart 0 Sign in  
X

[ CAS No. 372-47-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 372-47-4
Chemical Structure| 372-47-4
Chemical Structure| 372-47-4
Structure of 372-47-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 372-47-4 ]

Related Doc. of [ 372-47-4 ]

Alternatived Products of [ 372-47-4 ]

Product Details of [ 372-47-4 ]

CAS No. :372-47-4 MDL No. :MFCD00006374
Formula : C5H4FN Boiling Point : -
Linear Structure Formula :- InChI Key :CELKOWQJPVJKIL-UHFFFAOYSA-N
M.W : 97.09 Pubchem ID :67794
Synonyms :

Calculated chemistry of [ 372-47-4 ]

Physicochemical Properties

Num. heavy atoms : 7
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 24.19
TPSA : 12.89 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.35 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.37
Log Po/w (XLOGP3) : 0.77
Log Po/w (WLOGP) : 1.64
Log Po/w (MLOGP) : 0.87
Log Po/w (SILICOS-IT) : 1.93
Consensus Log Po/w : 1.32

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.56
Solubility : 2.67 mg/ml ; 0.0275 mol/l
Class : Very soluble
Log S (Ali) : -0.62
Solubility : 23.2 mg/ml ; 0.239 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.22
Solubility : 0.586 mg/ml ; 0.00604 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.17

Safety of [ 372-47-4 ]

Signal Word:Danger Class:3
Precautionary Statements:P210-P261-P305+P351+P338 UN#:1993
Hazard Statements:H225-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 372-47-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 372-47-4 ]
  • Downstream synthetic route of [ 372-47-4 ]

[ 372-47-4 ] Synthesis Path-Upstream   1~51

  • 1
  • [ 372-47-4 ]
  • [ 74-88-4 ]
  • [ 399-88-2 ]
YieldReaction ConditionsOperation in experiment
47%
Stage #1: With n-butyllithium; diisopropylamine In tetrahydrofuran; hexane at -78 - 25℃; for 2 h;
Stage #2: With sodium hydrogencarbonate In tetrahydrofuran; hexane; water
3-Fluoro-4-methylpyridine To a cooled (-780C) solution of Λ/,Λ/-diisopropylamine (15.92mL, 113.4mmol) in THF (14OmL) a solution of BuLi 2.5M in hexane (45.4ml, 113.4 mmol) was added dropwise over 30 minutes under an atmosphere of Argon. The mixture was stirred for 30 min. at - 780C and a solution of 3-fluoropyridine (1 Og1 103.1 mmol) in THF (5ml) was added. After 1h at -780C, the mixture was treated with MeI (7 ml, 113.4mmol) and then was allowed to reach 250C. A solution of NaHCO3 saturated (30ml) was added and the aqueous phase was extracted with diethyl ether. The organic layer was dried (MgSO4) and upon distillation the product was collected as a colourless liquid, bp 1300C, yield 5.3 g (47percent) δ 1 H-NMR (CDCI3): 8.25 (s, 1 H), 8.18 (m, 1 H), 7.02 (m, 1 H). ESI/MS m/e: 112 ([M+H]+, C6H6FN)
Reference: [1] Patent: WO2007/17096, 2007, A1, . Location in patent: Page/Page column 70-71
[2] Journal of Medicinal Chemistry, 2003, vol. 46, # 4, p. 461 - 473
[3] Patent: US6455532, 2002, B1,
[4] Patent: US6350745, 2002, B1, . Location in patent: Page column 15;16
[5] Patent: WO2006/35967, 2006, A1, . Location in patent: Page/Page column 98-99
  • 2
  • [ 2546-52-3 ]
  • [ 372-47-4 ]
  • [ 407-20-5 ]
Reference: [1] Tetrahedron, 1986, vol. 42, # 8, p. 2253 - 2262
  • 3
  • [ 372-47-4 ]
  • [ 402-66-4 ]
Reference: [1] European Journal of Organic Chemistry, 2005, # 10, p. 2116 - 2123
[2] European Journal of Organic Chemistry, 2005, # 10, p. 2116 - 2123
  • 4
  • [ 372-47-4 ]
  • [ 100-67-4 ]
  • [ 2176-45-6 ]
Reference: [1] Heterocycles, 2004, vol. 63, # 2, p. 297 - 308
  • 5
  • [ 372-47-4 ]
  • [ 124-38-9 ]
  • [ 393-53-3 ]
Reference: [1] European Journal of Organic Chemistry, 2005, # 10, p. 2116 - 2123
[2] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 5, p. 1086 - 1091
[3] Patent: WO2010/125985, 2010, A1, . Location in patent: Page/Page column 239-240
[4] Patent: EP2274983, 2011, A1, . Location in patent: Page/Page column 125-126
[5] Patent: US2011/39843, 2011, A1, . Location in patent: Page/Page column 79
[6] Patent: WO2011/40629, 2011, A1, . Location in patent: Page/Page column 208-209
[7] Patent: WO2011/49220, 2011, A1, . Location in patent: Page/Page column 208
[8] Patent: WO2011/49223, 2011, A1, . Location in patent: Page/Page column 208
[9] Patent: WO2011/49222, 2011, A1, . Location in patent: Page/Page column 212
  • 6
  • [ 372-47-4 ]
  • [ 393-53-3 ]
Reference: [1] Patent: WO2011/49221, 2011, A1, . Location in patent: Page/Page column 209
  • 7
  • [ 372-47-4 ]
  • [ 272-52-6 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 6, p. 1852 - 1856
  • 8
  • [ 288-13-1 ]
  • [ 372-47-4 ]
  • [ 25700-12-3 ]
Reference: [1] Green Chemistry, 2011, vol. 13, # 1, p. 42 - 45
  • 9
  • [ 372-47-4 ]
  • [ 1513-66-2 ]
Reference: [1] Science, 2013, vol. 342, # 6161, p. 956 - 960
  • 10
  • [ 372-47-4 ]
  • [ 17282-04-1 ]
YieldReaction ConditionsOperation in experiment
63%
Stage #1: With 1,4-diaza-bicyclo[2.2.2]octane; n-butyllithium In diethyl ether; hexane at -65℃; for 1.16667 h;
Stage #2: With hexachloroethane In diethyl ether; hexane at -40℃; for 2.25 h;
n-Butyllithium (2.5 M in hexanes; 230 ml, 0.57 mol) was added to a solution of 1, [4-DIAZABICYCLO] [[2.] 2. [2]] octane (pre-dried by azeotropic removal of water with toluene) (63. 8 g, 0.57 mol) in [ET20] (2. [5 1)] holding the temperature between-20 [AND-30°C.] After stirring for 1 h, the temperature was adjusted to-65°C and a solution of [3-FLUOROPYRIDINE] (50.0 g, 0.52 mol) in [ET20] (250 ml) was added dropwise over 10 min and the mixture stirred for a further 1 h. A solution of hexachloroethane (136.5 g, 0.58 mol) in [ET20] (350 ml) was then added dropwise over 15 min, holding the temperature [BELOW-60°C] and the mixture was stirred for 2 h, allowing the temperature to rise [TO-40°C.] The reaction was quenched by addition of saturated aqueous [NH4C1] solution (250 ml), warmed to ambient temperature and separated. The aqueous phase was extracted with [ET20] (2 x 250 ml) and the combined organics washed with further saturated aq. [NH4C1] (250 [ML),] dried over anhydrous [MGS04] and concentrated in vacuo. The residue was diluted with isohexane (150 ml) and washed with 2 N hydrochloric acid (3 x 100 ml), followed by 37percent hydrochloric acid (3 x 50 ml). The acid washings were then extracted with isohexane (3 x 100 ml), basified to pH 14 by careful addition of 4 N aqueous [NAOH] solution (500 ml) and re-extracted with [CH2CL2] (3 x 150 ml). The organic fractions were dried over anhydrous [MGS04] and concentrated in vacuo. The residue was purified by distillation (bp [74-82°C,] 1 atm) to afford 2-chloro-3- fluoropyridine as a straw-coloured oil (42.6 g, 63percent): [8H] (400 MHz, CDC13) 7.25-7. 30 [(1H,] m), 7.47-7. 51 [(1H,] m), 8.24 [(1H,] dd, [J 0.] 8 and 4.7) ; m/z (ES+) 132 (100percent, [[MH] +).] A mixture of 2-chloro-3-fluoropyridine (21.0 g, 0.16 mol), benzophenone imine (32.3 g, 0.18 mol), [CS2CO3] (73.0 g, 0.23 mol), BINAP (5.96 g, 9.6 mmol), palladium (II) acetate (1.45 g, 6.4 mmol) and toluene (370 ml) were heated to [95°C] for 42 h, then cooled, filtered and the residue extracted with further toluene (2 x 210 ml). The filtrate was washed with 0.5 N hydrochloric acid (200 ml) and saturated aqueous [NAHCO3] (200 ml), dried over anhydrous [MGS04] and concentrated in vacuo, affording crude benzhydrylidene [(3-FLUOROPYRIDIN-2-YL) AMINE] as a brown oil (49.4 g) which was used directly without further purification: [N7c/Z] (ES+) 277 (100percent, [[MH] +).] A mixture of crude [BENZHYDRYLIDENE] (3-fluoropyridin-2-yl) amine (49.4 g), 2-bromoacetaldehyde diethyl acetal (56 ml, 0.37 mol), 48percent hydrobromic acid (20 ml) and water (20 ml) were heated to [90°C] for 20 min. On cooling, the mixture was diluted with isopropanol (450 ml), NaHCOs [(68] g) was added cautiously, and the mixture filtered. The residue was washed with further isopropanol (450 [ML)] and the combined organics were stirred and heated to [50°C] for 18 h. On cooling, the solution was concentrated in vacuo and azeotroped with EtOAc (2 x 440 ml). The remaining mixture was suspended in EtOAc (400 ml), filtered and the residue washed with further EtOAc until the filtrate ran clear [(11).] The solid orange-coloured residue was then suspended between water (100 ml) and EtOAc (220 ml) and the aqueous phase pH adjusted to 8-9 by addition of saturated aqueous NaHCO3 solution (450 ml). The phases were separated and the aqueous extracted with further EtOAc (2 x 220 ml). The combined organic extracts were dried over anhydrous [MGS04] and concentrated in vacuo affording crude [8-FLUOROIMIDAZO [1, 2-APYRIDINE.] Purification was achieved by dissolving the crude material in EtOAc (1 l) and extracting with 2 N hydrochloric acid (5 x 50 [ML).] The acid washings were back-extracted with EtOAc (3 x 100 ml), adjusted to pH 11-12 using 4 N aqueous sodium hydroxide solution and re-extracted with EtOAc (5 x 100 [ML).] The combined organic fractions were washed with brine, dried over anhydrous [MGS04] and concentrated [17] vacua to afford 8- [FLUOROIMIDAZO] [[L,] 2-a] pyridine (11.4 [G, 76percent] from 2-chloro-3-fluoropyridine): [No.H ] [(400] MHz, CDCl3) 6.69-6. 74 [(1H,] m), 6.84-6. 87 [(1H,] m), 7.65-7. 66 (2H, m), 7.97 [(1H,] dd, J 1.0 and 6.8) [; M/Z (ES+)] 137 (100percent, [[MH]] +). A solution of bromine in [MEOH,] saturated with [KBR] (0. 86 M, 1.0 ml, 0.86 mmol) was added to a cooled, stirred solution of 8-fluoroimidazo[1, 2- pyridine (118 mg, 0. 86 mmol) and NaOAc (85 mg, 1.04 mmol) in methanol saturated with [KBR] (1.6 ml). After 2 min, the solution was poured into water (50 [ML)] and the resulting yellow solution extracted with [CH2CL2] (3 x 50 ml). The combined organic fractions were dried over anhydrous [NA2SO4] and concentrated in vacuo, yielding 3-bromo-8- [FLUOROIMIDAZO] [1, 2-a] pyridine as a yellow solid (155 mg, 83percent), used without further purification: [5H] (400 MHz, [CD13)] 6. [86-6.] 91 [(1H,] m), 6.95-6. 99 (1H, m), 7.65 [(1H,] s), 7.98 [(1H,] dd, [J 0.] 8 and 6.7) ; [M/Z] (ES+) 217 [(100percent,] [[MH] +),] 215 (100). [3-BROMO-8-FLUOROIMIDAZO] [1, [2-A] PYRIDINE,] 3- [[3- (5,] 5-dimethyl- [1, 3,2] dioxaborinan-2-yl) phenyl] pyridine (prepared as described in WO [01/90108),] tetrakis (triphenylphosphine) palladium [(0)] (42 mg, 0.036 [MMOL),] THF (3.6 ml) and 2 M aqueous [NA2CO3] solution were combined and the vigorously stirred mixture heated to [75°C] for 16 h. After cooling, the mixture was partitioned between 1 N aqueous [NAOH] solution (20 ml) and [CHZCL2] (20 ml) and the aqueous phase extracted with further [CHZCLZ] (20 ml). The combined organics were dried over anhydrous [NA2SO4] and concentrated in vacuo, and the residue purified by column chromatography (silica; 2percent [ETOH/ETOAC)] to afford the title imidazopyridine as a white amorphous solid (96 mg, 47percent): [SN] (400 MHz; DMSO) 6.93-6. 98 [(1H,] m), 7.21-7. 24 [(1H,] m), 7.51-7. 54 [(1H,] m), 7.68-7. 76 (2H, m), 7. 82 [(1H,] t, J [1.] 6), 7.94 [(1H,] s), 8.01 [(1H,] t, J 1.6), 8. 19-8.22 [(1H,] m), 8.54 [(1H,] dd, [J 0.] 8 and 7.0), 8.62 [(1H,] dd, J 1.6 and 4.7), 9.02 [(1H,] dd, J 0. 8 and 2.3) ; [MILZ] (ES+) 290 (30percent, [MH] +), 166 (100).
63%
Stage #1: With 1,4-diaza-bicyclo[2.2.2]octane; n-butyllithium In diethyl ether; hexane at -65℃; for 1.16667 h;
Stage #2: With hexachloroethane In hexanes; diethyl ether at -40℃; for 2.25 h;
n-Butyllithium (2.5 M in hexanes; 230 ml, 0.57 mol) was added to a solution of [1,] 4-diazabicyclo [2.2. [2]] octane (pre-dried by azeotropic removal of water with toluene) (63. [8] g, 0. [57] mol) in Et20 (2. [5 1)] holding the temperature between-20 [AND-30°C.] After stirring for 1 h, the temperature was adjusted to-65°C and a solution of 3-fluoropyridine (50.0 g, 0.52 mol) in [ET20] (250 [ML)] was added dropwise over 10 min and the mixture stirred for a further 1 h. A solution of hexachloroethane (136.5 g, 0. 58 mol) in [ET20] (350 [ML)] was then added dropwise over [15 MIN,] holding the temperature [BELOW-60°C] and the mixture was stirred for 2 h, allowing the temperature to rise [TO-40°C.] The reaction was quenched by addition of saturated aqueous [NH4CL] solution (250 ml), warmed to ambient temperature and separated. The aqueous phase was extracted with [ET20] (2 x 250 [ML)] and the combined organics washed with further saturated aq. NH4Cl (250 ml), dried over anhydrous [MGS04] and concentrated in uacuo. The residue was diluted with isohexane (150 ml) and washed with 2 N hydrochloric acid (3 x 100 ml), followed by 37percent hydrochloric acid (3 x 50 ml). The acid washings were then extracted with isohexane (3 x 100 ml), basified to pH 14 by careful addition of 4 N aqueous [NAOH] solution (500 ml) and re-extracted with [CH2CL2] (3 x 150 ml). The organic fractions were dried over anhydrous [MGS04] and concentrated in vacuo. The residue was purified by distillation (bp 74-82°C, 1 atm) to afford 2-chloro-3- fluoropyridine as a straw-coloured oil (42.6 g, 63percent): 8H (400 MHz, [CDCL3)] 7. [25-7. 30 (1H, M), 7.] 47-7.51 [(1H,] m), 8. 24 [(1H,] dd, J 0. 8 and 4.7) ; m/z (ES+) 132 (100percent, [MH] +). A mixture of 2-chloro-3-fluoropyridine (21.0 g, 0.16 mol), benzophenone imine (32.3 g, 0. 18 mol), Cs2CO3 (73.0 g, 0. [23 MOL), BINAP] (5.96 g, 9.6 mmol), palladium (II) acetate (1.45 g, 6.4 mmol) and toluene (370 ml) were heated to [95°C] for 42 h, then cooled, filtered and the residue extracted with further toluene (2 x 210 ml). The filtrate was washed with 0.5 N hydrochloric acid (200 ml) and saturated aqueous [NAHCO3] [(200] ml), dried over anhydrous [MGS04] and concentrated [IN VACUO, AFFORDING] crude benzhydrylidene [(3-FLUOROPYRIDIN-2-YL)] amine as a brown oil (49.4 g) which was used directly without further purification : [M/Z] [(ES+)] 277 (100percent, [



[MH]
NU+)-] A mixture of crude benzhydrylidene (3-fluoropyridin-2-yl) amine (49.4 g), 2-bromoacetaldehyde diethyl acetal (56 ml, 0.37 mol), 48percent hydrobromic acid (20 ml) and water (20 [ML)] were heated to [90°C] for 20 min. On cooling, the mixture was diluted with isopropanol (450 ml), [NAHCO3] [(68] g) was added cautiously, and the mixture filtered. The residue was washed with further isopropanol (450 ml) and the combined organics were stirred and heated to [50°C] for 18 h. On cooling, the solution was concentrated in vacuo and azeotroped with EtOAc (2 x 440 ml). The remaining mixture was suspended in EtOAc (400 ml), filtered and the residue washed with further EtOAc until the filtrate ran clear [(11).] The solid orange-coloured residue was then suspended between water (100 ml) and EtOAc (220 ml) and the aqueous phase pH adjusted to 8-9 by addition of saturated aqueous [NAHCO3] solution (450 ml). The phases were separated and the aqueous extracted with further EtOAc (2 x 220 ml). The combined organic extracts were dried over anhydrous MgS04 and concentrated in vacuo affording crude [8-FLUOROIMIDAZO [1, 2-A]] pyridine. Purification was achieved by dissolving the crude material in EtOAc [(11)] and extracting with 2 N hydrochloric acid (5 x 50 ml). The acid washings were back-extracted with EtOAc (3 x 100 ml), adjusted to pH 11-12 using 4 N aqueous sodium hydroxide solution and re-extracted with EtOAc (5 x 100 ml). The combined organic fractions were washed with brine, dried over anhydrous [MGS04] and concentrated in vacuo to afford 8- [FLUOROIMIDAZO] [1, 2-a] pyridine (11.4 g, 76percent from 2-chloro-3-fluoropyridine): 8H (400 MHz, CDCl3) 6.69-6. 74 [(1H,] m), 6. [84-6. 87 (1H,] m), 7.65-7. 66 (2H, m), 7.97 [(1H,] dd, J 1.0 and 6.8) [; M/Z] (ES+) 137 [(100percent,] [[MHJ+).] 8-Fluoroimidazo [1, 2-a] pyridine (68 mg, 0.50 mmol), 2-chloro-6- [TRIFLUOROMETHYLPYRIDINE] (182 mg, 1.0 [MMOL),] [CS2CO3] (326 mg, 1.0 mmol), tetrakis (triphenylphosphine) palladium (0) (57 mg, 0.05 mmol) and 1,4- dioxane (3 ml) were heated to [150°C] for 800 s in a Smith Personal [SYNTHESISERTM] using microwave irradiation. On cooling, the mixture was partitioned between [CH2CL2] (2 ml) and water (2 ml), and the phases separated using a [WHATMAN 5, UM] teflon filter tube. The organics were concentrated in vacuo and purified by column chromatography (silica; 90percent EtOAc/isohexane), yielding the title imidazopyridine as a white amorphous solid [(85] mg, 60percent): 8H (400 MHz; DMSO) 7.19-7. 24 [(1H, M),] 7.38-7. 43 [(1H,] m), 7.83 [(1H,] d, [J 7.] 4), 8. 20 [(1H,] t, J 8. 2), 8.38 [(1H,] s), 8.64 [(1H,] s), 9.64 [(1H,] dd, J 1.2 and 7.0) ; [WIZ] (ES+) 282 (100percent, [. MH]] +).
Reference: [1] Patent: WO2003/99816, 2003, A1, . Location in patent: Page 42-43
[2] Patent: WO2003/99817, 2003, A1, . Location in patent: Page 35
[3] Angewandte Chemie - International Edition, 2018, vol. 57, # 29, p. 9103 - 9107[4] Angew. Chem., 2018, vol. 130, p. 9241 - 9245,5
[5] Journal of Medicinal Chemistry, 2004, vol. 47, # 15, p. 3853 - 3864
  • 11
  • [ 280-57-9 ]
  • [ 372-47-4 ]
  • [ 67-72-1 ]
  • [ 17282-04-1 ]
YieldReaction ConditionsOperation in experiment
52% With n-butyllithium In tetrahydrofuran; diethyl ether; water Example 28A
2-chloro-3-fluoropyridine
1,4-Diazabicyclo[2.2.2]octane (5.78 g, 51.5 mmol) in diethyl ether (130 mL) was treated dropwise with n-butyllithium (32.2 mL, 51.5 mmol, 1.6M solution in hexanes) at -78° C.
The reaction mixture was warmed to -20° C. for 1 hour and then recooled to -78° C.
The recooled mixture was treated with 3-fluoropyridine (5.0 g, 51.5 mmol) in diethyl ether (5 mL) dropwise.
After stirring for 2 hours at -78° C., the mixture was treated with hexachloroethane (12.2 g, 51.5 mmol) in tetrahydrofuran (24 mL).
After stirring for one hour at -78° C., the reaction mixture was treated with a solution of water (15 mL) and tetrahydrofuran (25 mL).
The reaction mixture was warmed to 0° C. and, after 30 minutes, additional water and diethyl ether were added to the mixture.
The layers were separated and the aqueous phase extracted with diethyl ether (2*).
The combined ethereal layers were dried over Na2SO4, filtered, and the filtrate concentrated under reduced pressure.
The residue was chromatographed on flash silica gel (10percent ethyl acetate/hexanes) to afford 3.5 g (52percent yield) of the title compound. 1H NMR (300 MHz, DMSO-d6) δ7.54 (m, 1H), 7.96 (m, 1H), 8.31 (m, 1H); MS (ESI) m/e 154 (M+Na)+.
52% With n-butyllithium In tetrahydrofuran; diethyl ether; water Example 28A
2-chloro-3-fluoropyridine
1,4-Diazabicyclo[2.2.2]octane (5.78 g, 51.5 mmol) in diethyl ether (130 mL) was treated dropwise with n-butyllithium (32.2 mL, 51.5 mmol, 1.6M solution in hexanes) at -78° C.
The reaction mixture was warmed to -20° C. for 1 hour and then recooled to -78° C.
The recooled mixture was treated with 3-fluoropyridine (5.0 g, 51.5 mmol) in diethyl ether (5 mL) dropwise.
After stirring for 2 hours at -78 C, the mixture was treated with hexachloroethane (12.2 g, 51.5 mmol) in tetrahydrofuran (24 mL).
After stirring for one hour at -78° C., the reaction mixture was treated with a solution of water (15 mL) and tetrahydrofuran (25 mL).
The reaction mixture was warmed to 0° C. and, after 30 minutes, additional water and diethyl ether were added to the mixture.
The layers were separated and the aqueous phase extracted with diethyl ether (2*).
The combined ethereal layers were dried over Na2SO4, filtered, and the filtrate concentrated under reduced pressure.
The residue was chromatographed on flash silica gel (10percent ethyl acetate/hexanes) to afford 3.5 g (52percent yield) of the title compound. 1H NMR (300 MHz, DMSO-d6) δ 7.54 (m, 1H), 7.96 (m, 1H), 8.31 (m, 1H); MS (ESI) m/e 154 (M+Na)+.
52% With n-butyllithium In tetrahydrofuran; diethyl ether; water EXAMPLE 28A
2-chloro-3-fluoropyridine
1,4-Diazabicyclo[2.2.2]octane (5.78 g, 51.5 mmol) in diethyl ether (130 mL) was treated dropwise with n-butyllithium (32.2 mL, 51.5 mmol, 1.6M solution in hexanes) at -78° C.
The reaction mixture was warmed to -20° C. for 1 hour and then recooled to -78° C.
The recooled mixture was treated with 3-fluoropyridine (5.0 g, 51.5 mmol) in diethyl ether (5 mL) dropwise.
After stirring for 2 hours at -78 C., the mixture was treated with hexachloroethane (12.2 g, 51.5 mmol) in tetrahydrofuran (24 mL).
After stirring for one hour at -78° C., the reaction mixture was treated with a solution of water (15 mL) and tetrahydrofuran (25 mL).
The reaction mixture was warmed to 0° C. and, after 30 minutes, additional water and diethyl ether were added to the mixture.
The layers were separated and the aqueous phase extracted with diethyl ether (2*).
The combined ethereal layers were dried over Na2SO4, filtered, and the filtrate concentrated under reduced pressure.
The residue was chromatographed on flash silica gel (10percent ethyl acetate/hexanes) to afford 3.5 g (52percent yield) of the title compound. 1H NMR (300 MHz, DMSO-d6) δ7.54 (m, 1H), 7.96 (m, 1H), 8.31 (m, 1H); MS (ESI) m/e 154 (M+Na)+.
52% With n-butyllithium In tetrahydrofuran; diethyl ether; water EXAMPLE 28A
2-chloro-3-fluoropyridine
1,4-Diazabicyclo[2.2.2]octane (5.78 g, 51.5 mmol) in diethyl ether (130 mL) was treated dropwise with n-butyllithium (32.2 mL, 51.5 mmol, 1.6M solution in hexanes) at -78° C.
The reaction mixture was warmed to -20° C. for 1 hour and then recooled to -78° C.
The recooled mixture was treated with 3-fluoropyridine (5.0 g, 51.5 mmol) in diethyl ether (5 mL) dropwise.
After stirring for 2 hours at -78C, the mixture was treated with hexachloroethane (12.2 g, 51.5 mmol) in tetrahydrofuran (24 mL).
After stirring for one hour at -78° C., the reaction mixture was treated with a solution of water (15 mL) and tetrahydrofuran (25 mL).
The reaction mixture was warmed to 0° C. and, after 30 minutes, additional water and diethyl ether were added to the mixture.
The layers were separated and the aqueous phase extracted with diethyl ether (2*).
The combined ethereal layers were dried over Na2SO4, filtered, and the filtrate concentrated under reduced pressure.
The residue was chromatographed on flash silica gel (10percent ethyl acetate/hexanes) to afford 3.5 g (52percent yield) of the title compound. 1H NMR (300 MHz, DMSO-d6) δ 7.54 (m, 1H), 7.96 (m, 1H), 8.31 (m, 1H); MS (ESI) m/e 154 (M+Na)+.
52% With n-butyllithium In tetrahydrofuran; diethyl ether; water Example 28A
2-chloro-3-fluoropyridine
1,4-Diazabicyclo[2.2.2]octane (5.78 g, 51.5 mmol) in diethyl ether (130 mL) was treated dropwise with n-butyllithium (32.2 mL, 51.5 mmol, 1.6M solution in hexanes) at -78° C.
The reaction mixture was warmed to -20° C. for 1 hour and then recooled to -78° C.
The recooled mixture was treated with 3-fluoropyridine (5.0 g, 51.5 mmol) in diethyl ether (5 mL) dropwise.
After stirring for 2 hours at -78° C., the mixture was treated with hexachloroethane (12.2 g, 51.5 mmol) in tetrahydrofuran (24 mL).
After stirring for one hour at -78° C., the reaction mixture was treated with a solution of water (15 mL) and tetrahydrofuran (25 mL).
The reaction mixture was warmed to 0° C. and, after 30 minutes, additional water and diethyl ether were added to the mixture.
The layers were separated and the aqueous phase extracted with diethyl ether (2*).
The combined ethereal layers were dried over Na2SO4, filtered, and the filtrate concentrated under reduced pressure.
The residue was chromatographed on flash silica gel (10percent ethyl acetate/hexanes) to afford 3.5 g (52percent yield) of the title compound. 1H NMR (300 MHz, DMSO-d6) δ 7.54 (m, 1H), 7.96 (m, 1H), 8.31 (m, 1H); MS (ESI) m/e 154 (M+Na)+.

Reference: [1] Patent: US2003/162790, 2003, A1,
[2] Patent: US2002/169166, 2002, A1,
[3] Patent: US2002/169167, 2002, A1,
[4] Patent: US2004/127504, 2004, A1,
[5] Patent: US6960589, 2005, B2,
  • 12
  • [ 372-47-4 ]
  • [ 78948-09-1 ]
  • [ 2267-37-0 ]
  • [ 17282-04-1 ]
Reference: [1] Journal of Organic Chemistry, 1991, vol. 56, # 22, p. 6298 - 6301
  • 13
  • [ 372-47-4 ]
  • [ 2546-56-7 ]
YieldReaction ConditionsOperation in experiment
70.2%
Stage #1: With 2,3-dimethyl-2,3-diaminobutane; lithium diisopropyl amide In tetrahydrofuran; n-heptane; tert-butyl methyl ether; ethylbenzene at -50 - -40℃; for 74 h;
Stage #2: With hexachloroethane In tetrahydrofuran; n-heptane; tert-butyl methyl ether; ethylbenzene at -46 - -40℃; for 68 h;
A 30-gal Hastelloy reactor under nitrogen is charged with 2.5 kg (25.8 mole) of 3-fluoropyridine, 3.4 kg (29.6 mole, 1.2 equiv.) of tetramethylethylenediamine (TMEDA) and 20 L of methyl tert-butyl ether (MTBE). The solution is cooled to-50°C. A total of 15.5 L (12.6 L, 29.6 mole, 1.15 equiv.) of 1.9 M lithium diisopropylamide (LDA) solution (heptane/THF/ethylbenzene) is added over a period of 24 min while maintaining a temperature of-40 to-48 °C. The light-brown suspension is stirred for 50 rnin at-44 to-48°C. A solution of 7 kg (29.6 mole, 1.15 equiv.) of hexachloroethane in 20 L of MTBE is added over a period of 48 min while maintaining a temperature of-40 to-46°C. After stirring for 20 min at-40°C, the reaction is warmed to 0°C, then quenched into a reactor that contained 54 L of cold water. After stirring at 20-25°C for 20 min, the mixture is filtered through Celite to break a minor emulsion. The layers are separated. The aqueous layer is extracted with 5 L of MTBE. The organic layers are combined, then extracted with portions (1 x 21 L, 3 x 13 L) of 2 N HCl. The acidic aqueous phases are combined, partitioned with 16 L of MTBE, then basified to pH 6.19 by adding 6.5 kg of 50percent NaOH while maintaining a temperature of 15- 20 °C. The layers are separated. The aqueous phase is extracted with 10 L of MTBE. The combined organic phase is dried over 3.0 kg of sodium sulfate, then filtered and concentrated (56°C, 575 mbar during most of the concentration, 400 mbar for final concentration) to give 3.7 kg of 4-chloro-3-fluoropyridine, as a brown liquid, 2.4 kg corrected for 31. 2percent solvent by NMR and 95. 5percent purity by HPLC, 70.2percent yield.
Reference: [1] Patent: WO2005/35496, 2005, A1, . Location in patent: Page/Page column 32
[2] Chemistry - A European Journal, 2005, vol. 11, # 6, p. 1903 - 1910
[3] European Journal of Organic Chemistry, 2005, # 10, p. 2116 - 2123
[4] Angewandte Chemie - International Edition, 2018, vol. 57, # 29, p. 9103 - 9107[5] Angew. Chem., 2018, vol. 130, p. 9241 - 9245,5
  • 14
  • [ 372-47-4 ]
  • [ 769-54-0 ]
Reference: [1] Patent: WO2013/184757, 2013, A1,
  • 15
  • [ 372-47-4 ]
  • [ 107-31-3 ]
  • [ 40273-47-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2000, vol. 10, # 13, p. 1435 - 1438
  • 16
  • [ 372-47-4 ]
  • [ 68-12-2 ]
  • [ 40273-47-0 ]
Reference: [1] Tetrahedron, 1983, vol. 39, # 12, p. 2009 - 2021
[2] Tetrahedron, 2009, vol. 65, # 44, p. 8987 - 8994
  • 17
  • [ 372-47-4 ]
  • [ 109-94-4 ]
  • [ 40273-47-0 ]
Reference: [1] Tetrahedron, 1983, vol. 39, # 12, p. 2009 - 2021
  • 18
  • [ 372-47-4 ]
  • [ 68-12-2 ]
  • [ 31224-43-8 ]
YieldReaction ConditionsOperation in experiment
60%
Stage #1: With 1,4-diaza-bicyclo[2.2.2]octane; n-butyllithium In diethyl ether; hexane at -70 - -60℃; for 1.5 h;
Stage #2: at -70℃; for 1 h;
To a solution of DABCO (8.8 g, 78.2 mmol) in anhydrous diethyl ether (250 mL) at -25° C. was added n-BuLi (1.6 M in hexanes, 49 mL, 78.2 mmol). The mixture was stirred between -25 to -10° C. for 45 min and then cooled to -70° C. To the above solution was added 3-fluoropyridine (5.9 mL, 71 mmol) dropwise. The reaction was stirred between -70 to -60° C. for 1.5 h before DMF (11.0 mL, 2.0 eq.) was added. After 1.0 h stirring at -70° C., water (150 mL) was added and warmed up to rt. The layers were separated and the aqueous layer was extracted with methylene chloride (5.x.100 mL). The combined organic layer was washed with brine and dried over Na2SO4. After removal of solvent, the crude was purified by silica gel column chromatography using gradient EtOAc in hexanes to give 5.4 g (55-60percent yield) of 65A. 1H NMR (400 MHz, CDCl3) δ ppm 7.54-7.57 (m, 2H) 8.61 (d, J=2.20 Hz, 1H) 10.20 (s, 1H).
43%
Stage #1: With n-butyllithium; N,N,N,N,-tetramethylethylenediamine In diethyl ether; hexane at -78 - -20℃; for 2.41667 h;
Stage #2: at -78℃; for 2.16667 h;
n-Butyllithium (2.0 M in hexanes, 27.5 ml, 55 mmol) was added dropwise over 10 minutes at -200C to a solution of Λ/,Λ/,Λ/',Λ/'-tetramethylethylenediamine (7.5 ml, 50 mmol) in anhydrous diethyl ether (200 ml). The reaction mixture was stirred at -200C for 1 hour, then it was cooled to -78°C and 3- fluoropyridine (4.3 ml, 50 mmol), in diethyl ether (10 ml), was added dropwise over 15 minutes at - 78°C. The reaction mixture was stirred at" ι-78°C for 1 hour, after which time N1N- Dimethylformamide (4.3 ml, 55 mmol), in diethyl ether (10 ml), was added dropwise over 10 minutes at -78°C. It was stirred for 2 hours, then poured carefully onto a rapidly stirring ice/water mixture (300 ml). The mixture was stirred for 20 minutes, then diluted with ethyl acetate (200 ml). The layers were separated and the aqueous layer was further extracted with dichloromethane (4 x 50 ml). The organic solutions were combined and concentrated under reduced pressure, and the resulting crude product was purified by column chromatography on silica gel using EPO <DP n="49"/>dichloromethane:pentane as eluant (0:100 to 60:40 v/v) to yield the title compound (2.7 g, 43percent) as a solid.1H NMR (400MHz, CDCI3): δ 7.56-7.60 (m, 2H)1 8.63 (m, 1 H), 10.22 (s, 1 H).
Reference: [1] Patent: US2010/227894, 2010, A1, . Location in patent: Page/Page column 55
[2] Patent: WO2006/114706, 2006, A1, . Location in patent: Page/Page column 47-48
[3] Tetrahedron, 1983, vol. 39, # 12, p. 2009 - 2021
[4] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 23, p. 6998 - 7003
[5] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 6, p. 1852 - 1856
[6] Patent: WO2012/177896, 2012, A1, . Location in patent: Page/Page column 89-90
[7] Organic Process Research and Development, 2007, vol. 11, # 4, p. 716 - 720
  • 19
  • [ 372-47-4 ]
  • [ 60-29-7 ]
  • [ 31224-43-8 ]
Reference: [1] Patent: WO2012/177893, 2012, A2, . Location in patent: Page/Page column 102-103
  • 20
  • [ 372-47-4 ]
  • [ 31224-43-8 ]
Reference: [1] Patent: WO2005/12306, 2005, A2, . Location in patent: Page/Page column 49
  • 21
  • [ 372-47-4 ]
  • [ 31224-43-8 ]
YieldReaction ConditionsOperation in experiment
35% With n-butyllithium In diethyl ether; hexane; water; N,N-dimethyl-formamide 2-Formyl-3-fluoropyridine
Dry ethyl ether (500 mL), n-BuLi (1.6M in hexane, 62.5 mL, 0.1 mol), and dry 1,4-diazabicyclo[2.2.2]octane (DABCO) (11.56 g, 0.1 mol) were introduced into a 1 L flask under a dry N2 stream at -60° C. and the resulting cloudy solution was stirred for 1 hour at -20° C.
The mixture was then cooled to -75° C. and an ethyl ether (50 mL) solution of 3-fluoropyridine (9.81 g, 0.1 mol) was added dropwise and stirring continued for 11/2 hours at -60° C.
The mixture was recooled to -75° C., dry N,N-dimethylformamide (8.52 mL, 0.11 mol) dissolved in ethyl ether (50 mL) was added dropwise and the mixture stirred for 2 hours at -75° C. Water (175 mL) was introduced slowly at -10° C., the aqueous layer extracted with ethyl acetate (5*200 mL), and the combined extracts were dried over anhydrous sodium sulfate.
Solvent removal produced a dark brown oil which after vacuum distillation and purification by chromatography on silica gel provided 4.4 g (35percent) of the titled product as an off-white crystalline solid:
mp 48°-49° C.;
IR (CHCl3, cm-1) 3071, 3020, 2873, 2842, 1720, 1588, 1461, 1441;
1 H NMR (300 MHz, CDCl3) δ10.21 (s, 1H), 8.62 (m, 1H), 7.57 (m, 2H);
MS (FD) m/e 125 (M+);
Reference: [1] Patent: US5593993, 1997, A,
  • 22
  • [ 372-47-4 ]
  • [ 31224-43-8 ]
Reference: [1] Patent: US5716971, 1998, A,
  • 23
  • [ 372-47-4 ]
  • [ 109-94-4 ]
  • [ 31224-43-8 ]
Reference: [1] Tetrahedron, 1983, vol. 39, # 12, p. 2009 - 2021
  • 24
  • [ 372-47-4 ]
  • [ 40273-45-8 ]
Reference: [1] Tetrahedron, 1983, vol. 39, # 12, p. 2009 - 2021
  • 25
  • [ 372-47-4 ]
  • [ 22282-75-3 ]
Reference: [1] Tetrahedron Letters, 2004, vol. 45, # 36, p. 6697 - 6701
[2] Tetrahedron Letters, 1980, vol. 21, # 43, p. 4137 - 4140
[3] Heterocycles, 1993, vol. 35, # 1, p. 151 - 169
[4] Tetrahedron, 1993, vol. 49, # 1, p. 49 - 64
[5] Heterocycles, 1996, vol. 43, # 8, p. 1641 - 1652
[6] Patent: US6440972, 2002, B1,
  • 26
  • [ 372-47-4 ]
  • [ 22282-75-3 ]
Reference: [1] Tetrahedron, 2016, vol. 72, # 17, p. 2196 - 2205
  • 27
  • [ 372-47-4 ]
  • [ 22282-75-3 ]
  • [ 146141-04-0 ]
Reference: [1] Tetrahedron, 2016, vol. 72, # 17, p. 2196 - 2205
  • 28
  • [ 372-47-4 ]
  • [ 22282-75-3 ]
  • [ 146141-04-0 ]
Reference: [1] Tetrahedron, 2016, vol. 72, # 17, p. 2196 - 2205
  • 29
  • [ 372-47-4 ]
  • [ 78191-00-1 ]
  • [ 87674-20-2 ]
  • [ 87674-21-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 2, p. 679 - 683
[2] Patent: WO2011/56725, 2011, A1, . Location in patent: Page/Page column 46-47
  • 30
  • [ 372-47-4 ]
  • [ 87674-20-2 ]
Reference: [1] Tetrahedron, 1983, vol. 39, # 12, p. 2009 - 2021
  • 31
  • [ 372-47-4 ]
  • [ 78191-00-1 ]
  • [ 87674-20-2 ]
  • [ 87674-21-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 2, p. 679 - 683
[2] Patent: WO2011/56725, 2011, A1, . Location in patent: Page/Page column 46-47
  • 32
  • [ 372-47-4 ]
  • [ 87674-21-3 ]
Reference: [1] Tetrahedron, 1983, vol. 39, # 12, p. 2009 - 2021
  • 33
  • [ 372-47-4 ]
  • [ 75-07-0 ]
  • [ 87674-15-5 ]
YieldReaction ConditionsOperation in experiment
76%
Stage #1: With lithium diisopropyl amide In tetrahydrofuran; n-heptane; ethylbenzene at -78℃; for 2.5 h;
Stage #2: at -78℃; for 1.5 h;
Stage #3: With water; ammonium chloride In tetrahydrofuran; n-heptane; ethylbenzene at -30℃;
Into a stirred solution of 3-fluoropyridine (14 G, 144.2 MMOL) in anhydrous THF (150 mL), cooled TO-78°C and under argon, 79.2 mL (158. 6 MMOL) of a 2N solution of lithiumdiisopropylamide (LDA) in n-heptane, THF, ETHYLBENZENE, were slowly dropped in about 1H. After stirring for 2.5h a cooled solution (ca. 0°C) of acetaldehyde (8.9 ML, 158.5 MMOL) in 25 mL of anhydrous THF was slowly dropped and the reaction mixture was stirred AT-78°C for 1.5 h. The solution was warmed to-30°C and a solution of ammonium chloride (150g) in 700 mL of water was added. The mixture was extracted with ETHYLACETATE (3 x 400 mL) and the organic layers were washed with brine (4 x 200 mL) and dried over sodium sulfate. After concentration the oil was crystallized with n-hexane (40 mL) and 15.6 G (76percent yield) of 1- (3- fluoropyridin-4-yl) ethanol were obtained.
76%
Stage #1: With lithium diisopropyl amide In tetrahydrofuran; n-heptane; ethylbenzene at -78℃; for 3.5 h;
Stage #2: at -78℃; for 1.5 h;
Stage #3: With water; ammonium chloride In tetrahydrofuran; n-heptane; ethylbenzene at -30℃;
EXAMPLE 15
Preparation of 2-bromo-1-(3-fluoropyridin-4-yl)ethanone hydrobromide
Into a stirred solution of 3-fluoropyridine (14 g, 144.2 mmol) in anhydrous THF (150 mL), cooled to -78° C. and under argon, 79.2 mL (158.6 mmol) of a 2N solution of lithiumdiisopropylamide (LDA) in n-heptane, THF, ethylbenzene, were slowly dropped in about 1 h.
After stirring for 2.5 h a cooled solution (ca. 0° C.) of acetaldehyde (8.9 mL, 158.5 mmol) in 25 mL of anhydrous THF was slowly dropped and the reaction mixture was stirred at -78° C. for 1.5 h.
The solution was warmed to -30° C. and a solution of ammonium chloride (150 g) in 700 mL of water was added.
The mixture was extracted with ethylacetate (3*400 mL) and the organic layers were washed with brine (4*200 mL) and dried over sodium sulfate.
After concentration the oil was crystallized with n-hexane (40 mL) and 15.6 g (76percent yield) of 1-(3-fluoropyridin-4-yl)ethanol were obtained.
76%
Stage #1: With lithium diisopropyl amide In tetrahydrofuran; n-heptane; ethylbenzene at -78℃; for 3.5 h;
Stage #2: at -78 - -30℃; for 1.5 h;
Stage #3: With water; ammonium chloride In tetrahydrofuran; n-heptane; ethylbenzene at -30℃;
Example 2; 2-Bromo-1 -(3"fluoropyridin-4-yl)ethanone hydrobromide; Into a stirred solution of 3-fluoropyridine (14 g, 144.2 rnmol) in anhydrous THF (150 mL), cooled to -780C and under argon, 79.2 mL (158.6 mmol) of a 2N solution of lithiumdiisopropylamsde (LDA) in n-heptane, THF, ethylbenzene, were slowly dropped in about 1h. After stirring for 2.5h a cooled solution (ca. 0DC) of acetaldehyde (8.9 mL, 158.5 mmot) in 25 mL of anhydrous THF was slowly dropped and the reaction mixture was stirred at -78°C for <n="33"/>1.5 h. The solution was warmed to -30°C and a solution of ammonium chloride (15Og) in 700 mL of water was added. The mixture was extracted with ethylacetate (3 x 400 ml_) and the organic layers were washed with brine (4 x 200 mL) and dried over sodium sulfate. After concentration, the oil was crystallized with n-hexane (40 mL) and 15.6 g (76percent yield) of 1-{3- fiuoropyridin-4-yl)ethanol were obtained. A mixture of 1-(3-fiuoropyridin-4-y.)ethanoi (10 g, 70.3 mrnol) and commercial activated MnO2 (8 g, 92.1 mmol) in toluene (100 mL) were refluxed until disappearance of starting material. After cooling, the mixture was filtered on a bed of celite, the cake washed with toluene and the organic phases concentrated to give 3- f.uoro-4-acetyi pyridine (6.9 g, 70percent) that was used directly in the next step. To a stirred solution of 3-fluσro-4-acetyipyridine (5.3 g, 38.1 mmol} in glacial acetic acid (14 mL) and 48percent hydrobromic acid (5.3 mL), bromine (2 mL, 38 mmol) in glacial acetic acid (5.3 mL) was added slowly and dropwise. After addition, the solution was stirred at 60DC for 2.5 hour. This solution was cooled down and ethylacetate (70 mL) was added. After 30 minutes of stirring, the mixture was filtered and the solid was washed thoroughly with ethylacetate and dried. The title compound was obtained in 82percent yield (9.4 g).1H NMR (DMSOd6 /400 MHz) δ ppm 4.88 (s, 2 H) 7.83 (dd, 1 H) 8.62 (dd, 1 H) 8.81 (d, 1 H).
Reference: [1] Patent: WO2005/13986, 2005, A1, . Location in patent: Page/Page column 44
[2] Patent: US2007/142414, 2007, A1, . Location in patent: Page/Page column 18-19
[3] Patent: WO2007/96334, 2007, A1, . Location in patent: Page/Page column 31-32
[4] Tetrahedron, 1983, vol. 39, # 12, p. 2009 - 2021
  • 34
  • [ 372-47-4 ]
  • [ 97509-75-6 ]
Reference: [1] Patent: US2011/105753, 2011, A1,
[2] Patent: WO2011/56806, 2011, A1,
[3] Organic Process Research and Development, 2004, vol. 8, # 2, p. 192 - 200
[4] Patent: WO2003/90912, 2003, A1,
  • 35
  • [ 372-47-4 ]
  • [ 22282-75-3 ]
  • [ 146141-04-0 ]
Reference: [1] Tetrahedron, 2016, vol. 72, # 17, p. 2196 - 2205
  • 36
  • [ 372-47-4 ]
  • [ 22282-75-3 ]
  • [ 146141-04-0 ]
Reference: [1] Tetrahedron, 2016, vol. 72, # 17, p. 2196 - 2205
  • 37
  • [ 372-47-4 ]
  • [ 146141-04-0 ]
Reference: [1] Tetrahedron, 1993, vol. 49, # 1, p. 49 - 64
[2] Organic Letters, 2010, vol. 12, # 11, p. 2517 - 2519
  • 38
  • [ 2875-18-5 ]
  • [ 372-47-4 ]
  • [ 3512-18-3 ]
  • [ 76469-41-5 ]
  • [ 71902-33-5 ]
YieldReaction ConditionsOperation in experiment
24 %Spectr. With triethylsilane; [Rh(μ-H)(1,3-bis(diisopropylphosphanyl)propane)]2 In benzene-d6 at 50℃; for 48 h; Inert atmosphere General procedure: To a solution of fluoroarene (0.1 M) and HSiEt3 (0.1 M) in benzene-d6 in a PFA tube α,α,α-trifluorotoluene (1–2 μL) was added as internal standard. The PFA tube was closed by a Teflon plug, inserted into an NMR tube and an initial 19F{1H} NMR spectrum was recorded. Then [Rh(μ-H)(dippp)]2 (1) (0.005 M) was added and the reaction mixture was heated to 50 °C for 48 h. Hydrodefluorination of pentafluoropyridine gave 2,3,5,6-tetrafluoropyridine (11percent), 2,3,4,5-tetrafluoropyridine (11percent), 2,3,5-trifluoropyridine (8percent), 3,5-difluoropyridine (6percent) and 2-fluoropyridine (1percent) (TON = 11). Hydrodefluorination of 2,3,5,6-tetrafluoropyridine or 2,3,5,6-tetrafluoropyridine or 2,3,5,6-tetrafluoropyri-dine gave 2,3,5-trifluoropyridine (24percent), 2,3,6-trifluoropyridine (7percent), 3,5-difluoropyridine (15percent), 2,5-difluoropyridine (2percent) and 2-fluoropyridine (8percent) (TON = 18). Hydrodefluorination of hexafluoro-benzene or hexafluoroben-zene or hexa-fluorobenzene gave pentafluorobenzene (12percent) and 1,2,4,5-tetra-fluorobenzene or 1,2,4,5-tetrafluoro-benzene or 1,2,4,5-tetrafluoroben-zene (2percent) (TON = 3.1). Hydrodefluorination of pentafluorobenzene gave 1,2,4,5-tetrafluorobenzene (35percent), 1,2,3,4-tetrafluorobenzene (3percent), 1,2,4-trifluorobenzene (23percent) and 1,4-difluorobenzene (4percent) (TON = 19). Yields of organic hydrodefluorination products were determined from 19F{1H} NMR spectra by integration of product resonances versus the internal standard. Hydrodefluorination products were identified by NMR spectroscopy by comparison with literature data [23]. TON: number of hydrodefluorination steps/moles of 1.
Reference: [1] Journal of Fluorine Chemistry, 2013, vol. 155, p. 132 - 142
  • 39
  • [ 372-47-4 ]
  • [ 78191-00-1 ]
  • [ 194278-45-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 2, p. 679 - 683
  • 40
  • [ 2875-18-5 ]
  • [ 372-47-4 ]
  • [ 3512-18-3 ]
  • [ 76469-41-5 ]
  • [ 71902-33-5 ]
YieldReaction ConditionsOperation in experiment
24 %Spectr. With triethylsilane; [Rh(μ-H)(1,3-bis(diisopropylphosphanyl)propane)]2 In benzene-d6 at 50℃; for 48 h; Inert atmosphere General procedure: To a solution of fluoroarene (0.1 M) and HSiEt3 (0.1 M) in benzene-d6 in a PFA tube α,α,α-trifluorotoluene (1–2 μL) was added as internal standard. The PFA tube was closed by a Teflon plug, inserted into an NMR tube and an initial 19F{1H} NMR spectrum was recorded. Then [Rh(μ-H)(dippp)]2 (1) (0.005 M) was added and the reaction mixture was heated to 50 °C for 48 h. Hydrodefluorination of pentafluoropyridine gave 2,3,5,6-tetrafluoropyridine (11percent), 2,3,4,5-tetrafluoropyridine (11percent), 2,3,5-trifluoropyridine (8percent), 3,5-difluoropyridine (6percent) and 2-fluoropyridine (1percent) (TON = 11). Hydrodefluorination of 2,3,5,6-tetrafluoropyridine or 2,3,5,6-tetrafluoropyridine or 2,3,5,6-tetrafluoropyri-dine gave 2,3,5-trifluoropyridine (24percent), 2,3,6-trifluoropyridine (7percent), 3,5-difluoropyridine (15percent), 2,5-difluoropyridine (2percent) and 2-fluoropyridine (8percent) (TON = 18). Hydrodefluorination of hexafluoro-benzene or hexafluoroben-zene or hexa-fluorobenzene gave pentafluorobenzene (12percent) and 1,2,4,5-tetra-fluorobenzene or 1,2,4,5-tetrafluoro-benzene or 1,2,4,5-tetrafluoroben-zene (2percent) (TON = 3.1). Hydrodefluorination of pentafluorobenzene gave 1,2,4,5-tetrafluorobenzene (35percent), 1,2,3,4-tetrafluorobenzene (3percent), 1,2,4-trifluorobenzene (23percent) and 1,4-difluorobenzene (4percent) (TON = 19). Yields of organic hydrodefluorination products were determined from 19F{1H} NMR spectra by integration of product resonances versus the internal standard. Hydrodefluorination products were identified by NMR spectroscopy by comparison with literature data [23]. TON: number of hydrodefluorination steps/moles of 1.
Reference: [1] Journal of Fluorine Chemistry, 2013, vol. 155, p. 132 - 142
  • 41
  • [ 700-16-3 ]
  • [ 372-47-4 ]
  • [ 2875-18-5 ]
  • [ 71902-33-5 ]
Reference: [1] Journal of the Chemical Society - Perkin Transactions 1, 1998, # 10, p. 1705 - 1713
  • 42
  • [ 372-47-4 ]
  • [ 124-38-9 ]
  • [ 152126-31-3 ]
YieldReaction ConditionsOperation in experiment
1.2 g
Stage #1: With 1,4-diaza-bicyclo[2.2.2]octane; n-butyllithium In diethyl ether; hexane at -78 - -60℃; for 1 h;
Stage #2: at -78 - -10℃; for 0.333333 h;
To a solution of 1 ,4-diazabicyclo[2.2.2]octane (1.15 g, 10.3 mmol) in diethylether (50 ml) is added n- butyllithium (2.6M in hexane) (3.95 ml, 10.3 mmol) at -78 °C. The reaction mixture is stirred at -20 °C for 1 h followed by the addition of a solution of 3-fluoro-pyridine (1.00 g, 10.29 mmol) in diethylether (30 ml) at -78 °C. The yellow suspension is stirred at -60 °C for 1 h and then cooled to -78 °C followed by the addition of excess dry ice. The resulting solution allowed to warm to to -10 °C over 20 min. The precipitate is filtered and the residue is washed with ether which yields pure 3-fluoro-pyridine-2-carboxylic acid (1.20 g, 8.51 mmol, 83percent).
Reference: [1] Tetrahedron, 1998, vol. 54, # 42, p. 12859 - 12886
[2] Patent: WO2014/82737, 2014, A1, . Location in patent: Page/Page column 38
  • 43
  • [ 372-47-4 ]
  • [ 152126-31-3 ]
Reference: [1] European Journal of Organic Chemistry, 2005, # 10, p. 2116 - 2123
  • 44
  • [ 372-47-4 ]
  • [ 25015-63-8 ]
  • [ 329214-79-1 ]
Reference: [1] Organic Letters, 2018,
  • 45
  • [ 372-47-4 ]
  • [ 458532-97-3 ]
Reference: [1] Tetrahedron, 2002, vol. 58, # 22, p. 4369 - 4373
  • 46
  • [ 372-47-4 ]
  • [ 107504-08-5 ]
Reference: [1] European Journal of Organic Chemistry, 2005, # 10, p. 2116 - 2123
  • 47
  • [ 372-47-4 ]
  • [ 860296-24-8 ]
Reference: [1] European Journal of Organic Chemistry, 2005, # 10, p. 2116 - 2123
  • 48
  • [ 372-47-4 ]
  • [ 68-12-2 ]
  • [ 870063-60-8 ]
YieldReaction ConditionsOperation in experiment
88%
Stage #1: With lithium diisopropyl amide In tetrahydrofuran at -65 - -60℃; Inert atmosphere
Stage #2: at -60℃; for 1 h;
Stage #3: at 0℃; for 1 h;
[0122] A mechanically stirred solution of 3-fluoropyridine (600 g, 6.18 mol) in dry THE (6 L) was cooled to -65°C under N2 atmosphere. Lithium diisopropylamine solution in THE (3.4 L, 6.5 mol) was added over 2 hours while keeping the temperature below -60°C, and the reaction mixture was allowed to stir an additional hour below -60°C. Neat DME (804 mL, 10.4 mol) was then added over a one hour period at a rate as to maintain the temperature below -60°C. The reaction mixture was monitored by TLC for the complete consumption of 3-fluoropyridine starting material. Upon completion, the reaction mixture was then warmed to -10°C, and H20 (1.1 Kg, 62 mol) was added. Sodium borohyd ride (234 g, 6.18 mol) was then added in two portions over several minutes at 0°C with stirring. Then 6 M HCI (5.6 L) was added over 1 h while maintaining the reaction quenching temperature between 0-25°C. The reaction mixture was then heated to 40°C and stirred at this temperature overnight. To the mixture 6 M NaOH was then slowly added at 0-15°C to adjust the pH to 12. The aqueous layer was extracted with isopropylacetate (500 mL x 1, 1 Lx 3). The combined organic layers were washed with brine, dried over Na2504 and concentrated in vacuo. To the crude product was added heptane-isopropylacetate (1.2 L, v/v = 5/1), and the mixture was stirred at 0 °C for 30 mm. The product crystallized as a pale-yellow solid during stirring. The mixture was filtered, the filter cake was extracted with cooled heptane (250 mL x 1), collected and dried under vacuum to give the title compound as a pale-yellow solid (688 g, 88percent). 1H NMR (400 MHz, CDCI3) 6 8.42 (d, i = 4.8 Hz, 1H), 8.40 (d, i = 1.6 Hz, 1H), 7.49 (t, i = 4.8 Hz, 1H), 4.85 (s, 2H), 2.35 (br s, 1H).
88%
Stage #1: With lithium diisopropyl amide In tetrahydrofuran at -65 - -60℃; for 3 h; Inert atmosphere
Stage #2: at -60℃; for 1 h; Inert atmosphere
Stage #3: With sodium tetrahydroborate; water In tetrahydrofuran at -10 - 0℃; Inert atmosphere
Step 1. (3-fluoropyridin-4-yl)methanol [0171] A mechanically stirred solution of 3-fluoropyridine (600 g, 6.18 mol) in dry THF (6 L) was cooled to -65 °C under N2 atmosphere. Lithium diisopropylamine solution in THF (3.4 L, 6.5 mol) was added over 2 hours while keeping the temperature below -60 °C, and the reaction mixture was allowed to stir an additional hour below -60 °C. Neat DMF (804 mL, 10.4 mol) was then added over a one hour period at a rate as to maintain the temperature below -60 °C. The reaction mixture was monitored by TLC for the complete consumption of 3-fluoropyridine starting material. Upon completion, the reaction mixture was then warmed to -10 °C, and H20 (1.1 Kg, 62 mol) was added. Sodium borohydride (234 g, 6.18 mol) was then added in two portions over several minutes at 0 °C with stirring. Then 6 M HCI (5.6 L) was added over 1 h while maintaining the reaction quenching temperature between 0-25 °C. The reaction mixture was then heated to 40 °C and stirred at this temperature overnight. To the mixture 6 M NaOH was then slowly added at 0-15 °C to adjust the pH to 12. The aqueous layer was extracted with isopropylacetate (500 m L x 1, 1 L x 3). The combined organic layers were washed with brine, dried over Na2S04 and concentrated in vacuo. To the crude product was added heptane-isopropylacetate (1.2 L, v/v = 5/1), and the mixture was stirred at 0 °C for 30 min. The product crystallized as a pale-yellow solid during stirring. The mixture was filtered, the filter cake was extracted with cooled heptane (250 m L x 1), collected and dried under vacuum to give the title compound as a pale-yellow solid (688 g, 88percent). 1H N M R (400 M Hz, CDCI3) δ 8.42 (d, J = 4.8 Hz, 1H), 8.40 (d, J = 1.6 Hz, 1H), 7.49 (t, J = 4.8 Hz, 1H), 4.85 (s, 2H), 2.35 (br s, 1H).
Reference: [1] Patent: WO2016/49048, 2016, A1, . Location in patent: Paragraph 0122
[2] Patent: WO2016/100349, 2016, A2, . Location in patent: Paragraph 0171
  • 49
  • [ 372-47-4 ]
  • [ 1352625-33-2 ]
Reference: [1] Patent: WO2012/45729, 2012, A1,
  • 50
  • [ 372-47-4 ]
  • [ 1352625-29-6 ]
Reference: [1] Patent: WO2012/45729, 2012, A1,
  • 51
  • [ 372-47-4 ]
  • [ 1352625-27-4 ]
Reference: [1] Patent: WO2012/45729, 2012, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 372-47-4 ]

Fluorinated Building Blocks

Chemical Structure| 21717-96-4

[ 21717-96-4 ]

2-Amino-5-fluoropyridine

Similarity: 0.85

Chemical Structure| 399-88-2

[ 399-88-2 ]

3-Fluoro-4-methylpyridine

Similarity: 0.85

Chemical Structure| 407-21-6

[ 407-21-6 ]

3-Fluoro-5-methylpyridine

Similarity: 0.83

Chemical Structure| 71902-33-5

[ 71902-33-5 ]

3,5-Difluoropyridine

Similarity: 0.83

Chemical Structure| 15931-15-4

[ 15931-15-4 ]

3-Fluoro-2-methylpyridine

Similarity: 0.79

Related Parent Nucleus of
[ 372-47-4 ]

Pyridines

Chemical Structure| 21717-96-4

[ 21717-96-4 ]

2-Amino-5-fluoropyridine

Similarity: 0.85

Chemical Structure| 399-88-2

[ 399-88-2 ]

3-Fluoro-4-methylpyridine

Similarity: 0.85

Chemical Structure| 407-21-6

[ 407-21-6 ]

3-Fluoro-5-methylpyridine

Similarity: 0.83

Chemical Structure| 71902-33-5

[ 71902-33-5 ]

3,5-Difluoropyridine

Similarity: 0.83

Chemical Structure| 15931-15-4

[ 15931-15-4 ]

3-Fluoro-2-methylpyridine

Similarity: 0.79